Publications by authors named "Thomas Johns"

Claim this Profile
D
Development of a Medication Safety and Quality Survey for Small Rural Hospitals.
Almut G Winterstein, Thomas E Johns, Kyle N Campbell, Joel Libby, Bob Pannell

J Patient Saf· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a complexity score to rank hospitalized patients at risk for preventable adverse drug events.
Almut G Winterstein, Ben Staley, Carl Henriksen, Dandan Xu, Gloria Lipori, Thomas Johns

Am J Health Syst Pharm· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying and characterizing preventable adverse drug events for prioritizing pharmacist intervention in hospitals.
Nakyung Jeon, Ben Staley, Thomas Johns, Glori Pflugfelder Lipori, Babette Brumback

Am J Health Syst Pharm· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activated partial thromboplastin time versus antifactor Xa heparin assay in monitoring unfractionated heparin by continuous intravenous infusion.
David J Guervil, Amy F Rosenberg, Almut G Winterstein, Neil S Harris, Thomas E Johns

Ann Pharmacother· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Planning for pharmacy health information technology in critical access hospitals.
Abraham G Hartzema, Almut G Winterstein, Thomas E Johns, Jessica M De Leon, Warren Bailey

Am J Health Syst Pharm· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medication safety infrastructure in critical-access hospitals in Florida.
Almut G Winterstein, Abraham G Hartzema, Thomas E Johns, Jessica M De Leon, Kathie McDonald

Am J Health Syst Pharm· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Causes of hyperglycemia and hypoglycemia in adult inpatients.
Wendy D Smith, Almut G Winterstein, Thomas Johns, Eric Rosenberg, Brian C Sauer

Am J Health Syst Pharm· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resource use and cost of care for patients hospitalised with community acquired pneumonia: impact of adherence to infectious diseases society of america guidelines.
Joanne J Orrick, Richard Segal, Thomas E Johns, Wayne Russell, Feng Wang

Pharmacoeconomics· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nature and causes of clinically significant medication errors in a tertiary care hospital.
Almut G Winterstein, Thomas E Johns, Eric I Rosenberg, Randy C Hatton, Ricardo Gonzalez-Rothi

Am J Health Syst Pharm· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nature of preventable adverse drug events in hospitals: a literature review.
Penkarn Kanjanarat, Almut G Winterstein, Thomas E Johns, Randy C Hatton, Ricardo Gonzalez-Rothi

Am J Health Syst Pharm· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying clinically significant preventable adverse drug events through a hospital's database of adverse drug reaction reports.
Almut G Winterstein, Randy C Hatton, Ricardo Gonzalez-Rothi, Thomas E Johns, Richard Segal

Am J Health Syst Pharm· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombocytopenia secondary to linezolid administration: what is the risk?
Joanne J Orrick, Thomas Johns, Jennifer Janelle, Reuben Ramphal

Clin Infect Dis· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis